CC
AURA icon

Corton Capital’s Aura Biosciences AURA Stock Holding History

Corton Capital’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-17,189
Closed -$141K – 190
2024
Q4 		$141K Sell
17,189
-13,230
-43% -$125K 0.08% 312
2024
Q3 		$271K Buy
30,419
+5,235
+21% +$44.9K 0.13% 229
2024
Q2 		$190K Buy
+25,184
New +$184K 0.1% 388

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Corton Capital's AURA Position: Q1 2025 in Review

Corton Capital sold out of Aura Biosciences (AURA) in Q1 2025, closing a stake of 17,189 shares — an estimated $141K sold.

Corton Capital first reported a position in AURA in Q2 2024 and held it in 3 quarters. The position peaked at $271K in Q3 2024. 94 funds tracked by Wall St. Rank hold AURA as of Q1 2025.

  • Corton Capital reported no remaining Aura Biosciences position as of Q1 2025 after selling out during the quarter.
  • Corton Capital sold 17,189 Aura Biosciences shares in Q1 2025, an estimated $141K.
  • Corton Capital first reported a position in Aura Biosciences in Q2 2024 and held it in 3 quarters.
  • Corton Capital's Aura Biosciences position peaked at $271K in Q3 2024.
  • 94 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2025.

Based on Corton Capital's 13F filing for Q1 2025, filed 7 May 2025.